Nov 16,2022

Lilly to Participate in Evercore ISI HealthCONx Conference

Eli Lilly and Company will attend the fifth annual Evercore ISI HealthCONx Conference on Wednesday, Nov. 30, 2022. Jacob Van Naarden, Lilly executive vice president and CEO of Loxo@Lilly, and David Hyman, M.D., chief medical officer, Loxo@Lilly, will participate in a fireside chat at 12:10 p.m., Eastern time.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 16,2022

Marpai Announces Virta as Diabetes Premium Health Partner

Marpai, Inc., an AI-technology company transforming self-funded employer health plans, announces the addition of Virta Health as a Premium Health Partner to improve health outcomes for health plan members with diabetes. Under its universal Marpai Cares offering for self-funded health plans, Marpai delivers Proactive Targeted Health Interventions aimed at improving health outcomes and trajectories for at-risk health plan members. After rigorous analysis by Marpai data scientists and clinicians, Virta has been selected as the clinical solution for treating diabetes.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Nov 16,2022

Abbott FreeStyle LibreLink app now pairs with Novo Nordisk insulin pens in UK

Novo Nordisk announced that users of the Abbott FreeStyle LibreLink app can connect to its smart insulin pens. People living with diabetes in the United Kingdom can connect the app to the Novo Nordisk smart, connected pens. Users of the Abbott FreeStyle LibreLink app with FreeStyle Libre glucose sensing technology can see a range of information related to their diabetes. This includes dose timing and the amount of insulin taken, plus how those metrics impact their individual glucose patterns.

COLLABORATION PARTNERSHIP

#connected device

#insulin pen

#cgm

View Analyst & Ambassador Comments
Go to original news
Nov 16,2022

Tandem Diabetes Care Earns Great Place to Work Certification™

Tandem Diabetes Care is proud to announce its Great Place to Work Certification™, a prestigious award based entirely on results from in-depth employee surveys around their experience working at the company. This year, 84 percent of Tandem employees said it’s a great place to work – 27 points higher than the average participating company in the United States.

View Analyst & Ambassador Comments
Go to original news
Nov 17,2022

Antidote Health Launches Telemedicine Service for Prediabetes and Type 2 Diabetes

Antidote Health, a telehealth company, is proud to announce the launch of its new service for prediabetes and type 2 diabetes care, next to its primary, mental health, hypertension services. Led by Dr. Lyle Mitzner, the comprehensive service addresses the soaring diabetes epidemic in the U.S. and underscores Antidote Health’s commitment to ensure everyone has access to affordable high-quality healthcare, no matter their race, location or circumstance.

PRODUCT

#telehealth

View Analyst & Ambassador Comments
Go to original news
Nov 17,2022

K Health Platform Now Addressing Weight Loss to Help Prevent and Manage Multiple Chronic Conditions

Clinical healthcare company K Health announced today that the remote Primary Care program available on its platform now includes online medical weight management to treat obesity and help prevent related chronic conditions like hypertension and type 2 diabetes. K Health has partnered with leaders in the healthcare space to tackle chronic disease, most recently through its collaboration with Mayo Clinic Platform on the development of an artificial intelligence (AI) predictive model that uses Mayo Clinic data to help doctors optimize hypertension treatment.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Nov 17,2022

Indonesia Digital Diabetes Management Market Outlook 2020-2030: Growing Adoption of Digital Healthcare Solutions Drives Sector

The Indonesia digital diabetes management market is anticipated to grow with a CAGR of 17.97% during the forecast period, i.e., 2021-2030. Factors such as the increasing prevalence of diabetes in Indonesia, along with the growing adoption of digital health solutions to tackle the disease are projected to contribute to the growth of the market in the coming years.

View Analyst & Ambassador Comments
Go to original news
Nov 17,2022

Vida Health Promotes Richard Frank to Chief Medical Officer

Vida Health today announced the promotion of Richard Frank, MD to Chief Medical Officer. Dr. Frank joined Vida in January of 2022 as SVP of Medical Affairs where he supported the company’s health plan strategy, health economics, and outcomes research strategy.

View Analyst & Ambassador Comments
Go to original news
Nov 17,2022

FDA identifies Insulet Omnipod DASH battery recall as Class I

The FDA posted a notice saying the recall of Insulet's Omnipod DASH Insulin Management System Personal Diabetes Manager is a Class I, the most serious recall indicating the devices could cause serious injuries or death. The Massachusetts-based company's system consists of two parts: A wearable and tubeless pump that delivers insulin, dubbed the Pod, and a remote controller with a battery pack called the Personal Diabetes Manager (PDM).

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Nov 21,2022

How Sernova seeks to treat insulin-dependent diabetes with its Cell Pouch System

When Dr. Philip Toleikis joined Sernova in 2009, the company’s technology appeared as more of a concept than anything else. But, he saw the potential for something groundbreaking: A cure for type 1 diabetes (T1D). Sernova’s ongoing Phase 1/2 clinical trial evaluates six patients with long-standing, insulin-dependent T1D.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES